NoticiasCon ayuda de IA

Allergan Aesthetics Expands SKINVIVE® To 57 Markets, Driving Global Focus On Skin Quality And Hydration

Allergan Aesthetics expands SKINVIVE® by JUVÉDERM® to 57 countries, highlighting global demand for healthy, radiant skin.

Vaibhavi M.
Por Vaibhavi M.
Experto en la materia (B.Pharm) · Pharma Now
24 sept 2025Updated Sep 25, 2025 · 2 min de lectura
Allergan Aesthetics Expands SKINVIVE® To 57 Markets, Driving Global Focus On Skin Quality And Hydration
Reportaje con ayuda de IA
Reviewed by Vaibhavi M., Experto en la materia (B.Pharm) · Pharma Now

Allergan Aesthetics, an AbbVie company, announced the global expansion of SKINVIVE® by JUVÉDERM®, set to launch in 35 new markets in 2025, bringing its availability to 57 countries worldwide. This expansion reflects the company’s commitment to advancing skin quality solutions and meeting the growing global demand for healthy, radiant skin. SKINVIVE® is designed to improve skin smoothness and hydration with a single treatment, aligning with the shift in aesthetics toward subtle, natural-looking results.

"This extensive rollout marks an exciting new era for Allergan Aesthetics, placing a greater emphasis on skin quality. As we observe a shift in consumer behavior towards skin health-focused solutions, we're committed to evolving our injectable portfolio. Through introducing innovative injection techniques, new treatment approaches with AA Signature™, and strategic product launches worldwide, our mission is to help empower practitioners deliver the best possible results for their patients,," said Mark Wilson, SVP, International Allergan Aesthetics. 

Consumer research conducted by Allergan Aesthetics highlights a strong emotional connection between women’s perceptions of their skin quality and their overall well-being. Findings reveal that 94% of people want to improve their facial skin quality, with hydration and radiance being top priorities across age groups. Attributes such as smoothness, glow, and hydration play a key role in attractiveness, perceived youthfulness, and health. Patients are increasingly choosing aesthetic treatments that enhance natural skin quality rather than making dramatic facial changes.

To support this evolving consumer demand, Allergan Aesthetics is promoting its AA Signature™ holistic approach, which integrates SKINVIVE® with other treatment modalities to deliver comprehensive skin quality improvements. Already launched in 25 countries, AA Signature™ will be featured at the Aesthetic Anti-Aging Medicine World Congress (AMWC) in Dubai on October 1, with expert-led panels and a symposium on advancing skin quality. Through these initiatives, Allergan Aesthetics continues to position itself as a leader in global skin quality innovation.

Vaibhavi M.
Written by
Vaibhavi M.
Experto en la materia (B.Pharm) · Pharma Now

Reporting on the science, business and regulation shaping the pharmaceutical industry.

Discussion

Cargando la conversación…

Más de Pharma News

Todos los artículos →